250 related articles for article (PubMed ID: 31396466)
1. The Role of Anti-calcitonin Gene-related Peptide in Migraine and its Implication in Developing Countries: A Reasonable Option to Consider Despite Higher Cost.
Akhtar A
Cureus; 2019 Jun; 11(6):e4796. PubMed ID: 31396466
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.
Schoenen J; Manise M; Nonis R; Gérard P; Timmermans G
Rev Neurol (Paris); 2020 Dec; 176(10):788-803. PubMed ID: 32758365
[TBL] [Abstract][Full Text] [Related]
3. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
4. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
Yuan H; Spare NM; Silberstein SD
Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
[TBL] [Abstract][Full Text] [Related]
5. Role of CGRP in Migraine.
Edvinsson L
Handb Exp Pharmacol; 2019; 255():121-130. PubMed ID: 30725283
[TBL] [Abstract][Full Text] [Related]
6. Blocking CGRP in migraine patients - a review of pros and cons.
Deen M; Correnti E; Kamm K; Kelderman T; Papetti L; Rubio-Beltrán E; Vigneri S; Edvinsson L; Maassen Van Den Brink A;
J Headache Pain; 2017 Sep; 18(1):96. PubMed ID: 28948500
[TBL] [Abstract][Full Text] [Related]
7. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin Gene-Related Peptide Antagonists as a Savior in Episodic and Chronic Migraine: A Review.
Pervez H; Khemani L; Khan MA; Seedat AM; Roshan F
Cureus; 2020 Jun; 12(6):e8711. PubMed ID: 32699706
[TBL] [Abstract][Full Text] [Related]
9. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
Khan S; Olesen A; Ashina M
Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
[TBL] [Abstract][Full Text] [Related]
10. Headache: Treatment update.
Ogunlaja OI; Goadsby PJ
eNeurologicalSci; 2022 Dec; 29():100420. PubMed ID: 36636337
[TBL] [Abstract][Full Text] [Related]
11. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
Edvinsson L
Br J Clin Pharmacol; 2015 Aug; 80(2):193-9. PubMed ID: 25731075
[TBL] [Abstract][Full Text] [Related]
12. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
Edvinsson L; Warfvinge K
Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
[TBL] [Abstract][Full Text] [Related]
13. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
[TBL] [Abstract][Full Text] [Related]
14. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
15. [Anti-CGRP-based Migraine Medications: A Comprehensive Overview].
Triller P; Raffaelli B
Fortschr Neurol Psychiatr; 2024 Mar; ():. PubMed ID: 38547904
[TBL] [Abstract][Full Text] [Related]
16. Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.
Alsaadi T; Suliman R; Santos V; Al Qaisi I; Carmina P; Aldaher B; Haddad S; Bader Y
Neurol Ther; 2024 Apr; 13(2):465-473. PubMed ID: 38361080
[TBL] [Abstract][Full Text] [Related]
17. Novel FDA-approved zavegepant drug for treating migraine.
Ahmed U; Saleem MM; Osman MA; Shamat SF
Ann Med Surg (Lond); 2024 Feb; 86(2):923-925. PubMed ID: 38333255
[TBL] [Abstract][Full Text] [Related]
18. CGRP antagonists and antibodies for the treatment of migraine.
Vécsei L; Szok D; Csáti A; Tajti J
Expert Opin Investig Drugs; 2015 Jan; 24(1):31-41. PubMed ID: 25219387
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.
Santos-Lasaosa S; Belvís R; Cuadrado ML; Díaz-Insa S; Gago-Veiga A; Guerrero-Peral AL; Huerta M; Irimia P; Láinez JM; Latorre G; Leira R; Pascual J; Porta-Etessam J; Sánchez Del Río M; Viguera J; Pozo-Rosich P
Neurologia (Engl Ed); 2022 Jun; 37(5):390-402. PubMed ID: 31326215
[TBL] [Abstract][Full Text] [Related]
20. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
